ResearcherVirginia Cancer SpecialistsActive in the last 2 years
Alexander I. Spira
Matched on ORCID iD 0000-0003-1303-0447; OpenAlex author ID A5044613951. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 46
2023: 1 trial · 2024: none · 2025: none · 2026: 3 papers
Papers 3
- Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer. Co-author DOI 10.1038/s41591-026-04537-w↗
- Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2505783↗
- Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2600752↗
Trials 1
Closest collaborators
The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wungki Park · 3 shared papers, 2026 · strength 0.60
- Paper Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer. DOI 10.1056/nejmoa2505783↗
- Paper Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer. DOI 10.1056/nejmoa2600752↗
- Paper Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategie… DOI 10.1038/s41591-026-04537-w↗
- Alexander Starodub · 2 shared papers, 2026 · strength 0.41
- Brian Matthew Wolpin · 2 shared papers, 2026 · strength 0.41
- Minal A. Barve · 2 shared papers, 2026 · strength 0.41
- David S. Hong · 2 shared papers, 2026 · strength 0.41
- Ignacio Garrido‐Laguna · 2 shared papers, 2026 · strength 0.41
- Joel Randolph Hecht · 1 shared paper, 2026 · strength 0.23
- Nilofer Saba Azad · 1 shared paper, 2026 · strength 0.23
- Kyaw Lwin Aung · 1 shared paper, 2026 · strength 0.23
- Mireya Cazorla · 1 shared trial, 2023 · strength 0.22
- Andrés Muñoz · 1 shared trial, 2023 · strength 0.22
- Carmen Guillén‐Ponce · 1 shared trial, 2023 · strength 0.22
- Eva Martínez de Castro · 1 shared trial, 2023 · strength 0.22
- Teresa Macarulla · 1 shared trial, 2023 · strength 0.22
- Roberto Pazo · 1 shared trial, 2023 · strength 0.22
- Rocío García · 1 shared trial, 2023 · strength 0.22
- Alana TH Nguyen · 1 shared trial, 2023 · strength 0.22
- Christopher Nevala-Plagemann · 1 shared trial, 2023 · strength 0.22
- Arjun Mittra · 1 shared trial, 2023 · strength 0.22
- Berta Laquente · 1 shared trial, 2023 · strength 0.22
- Miriam Lobo · 1 shared trial, 2023 · strength 0.22
- Inmaculada Gallego · 1 shared trial, 2023 · strength 0.22
- Edward Kim · 1 shared trial, 2023 · strength 0.22
- Tara E Seery · 1 shared trial, 2023 · strength 0.22
- MD, FACP Vivek R Sharma · 1 shared trial, 2023 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.